Pre-operative anaemia, intra-operative hepcidin concentration and acute kidney injury after cardiac surgery: a retrospective observational study

Anaesthesia

Volumn 73, Issue 9, 2018, Pages 1097-1102

  Karkouti, K ^a   Yip, P ^b   Chan, C ^b   Chawla, L ^c,d   Rao, V ^b  

^a UNIVERSITY HEALTH NETWORK   (Canada)

^b TORONTO GENERAL HOSPITAL   (Canada)

^c GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

^d La Jolla Pharmaceutical Company   (United States)

Author keywords

anaemia; cardiopulmonary bypass; peri operative renal failure

Indexed keywords

CREATININE; HEPCIDIN; BIOLOGICAL MARKER;

ACUTE KIDNEY FAILURE; ANEMIA; ARTICLE; CARDIOPULMONARY BYPASS; FEMALE; HEART SURGERY; HUMAN; IRON HOMEOSTASIS; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; RENAL REPLACEMENT THERAPY; RETROSPECTIVE STUDY; SURGICAL PATIENT; ADULT; AGED; BLOOD; COMPLICATION; MIDDLE AGED; POSTOPERATIVE COMPLICATION; PREOPERATIVE PERIOD; RISK FACTOR; VERY ELDERLY; YOUNG ADULT;

ACUTE KIDNEY INJURY; ADULT; AGED; AGED, 80 AND OVER; ANEMIA; BIOMARKERS; CARDIAC SURGICAL PROCEDURES; CARDIOPULMONARY BYPASS; FEMALE; HEPCIDINS; HUMANS; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; PREOPERATIVE PERIOD; RETROSPECTIVE STUDIES; RISK FACTORS; YOUNG ADULT;

EID: 85043480571     PISSN: 00032409     EISSN: 13652044     Source Type: Journal    
DOI: 10.1111/anae.14274     Document Type: Article

References (33)

1. Thiele RH, Isbell JM, Rosner MH. AKI associated with cardiac surgery. Clinical Journal of the American Society of Nephrology 2015; 10: 500–14
2. Karkouti K, Wijeysundera DN, Yau TM, et al. Acute kidney injury after cardiac surgery: focus on modifiable risk factors. Circulation 2009; 119: 495–502
3. Grams ME, Sang Y, Coresh J, et al. Candidate surrogate end points for ESRD after AKI. Journal of the American Society of Nephrology 2016; 27: 2851–9
4. Fowler AJ, Ahmad T, Phull MK, Allard S, Gillies MA, Pearse RM. Meta-analysis of the association between preoperative anaemia and mortality after surgery. Bristish Journal of Surgery 2015; 102: 1314–24
5. Martines AM, Masereeuw R, Tjalsma H, Hoenderop JG, Wetzels JF, Swinkels DW. Iron metabolism in the pathogenesis of iron-induced kidney injury. Nature Reviews Nephrology 2013; 9: 385–98
6. Karkouti K, Wijeysundera DN, Yau TM, et al. Advance targeted transfusion in anemic cardiac surgical patients for kidney protection: an unblinded randomized pilot clinical trial. Anesthesiology 2012; 116: 613–21
7. Karkouti K, Grocott HP, Hall R, et al. Interrelationship of preoperative anemia, intraoperative anemia, and red blood cell transfusion as potentially modifiable risk factors for acute kidney injury in cardiac surgery: a historical multicentre cohort study. Canadian Journal of Anesthesia 2015; 62: 377–84
8. Walker VJ, Agarwal A. Targeting iron homeostasis in acute kidney injury. Seminars in Nephrology 2016; 36: 62–70
9. Haase M, Bellomo R, Haase-Fielitz A. Novel biomarkers, oxidative stress, and the role of labile iron toxicity in cardiopulmonary bypass-associated acute kidney injury. Journal of the American College of Cardiology 2010; 55: 2024–33
10. Leaf DE, Swinkels DW. Catalytic iron and acute kidney injury. American Journal of Physiology Renal Physiology 2016; 311: F871–F876
11. Hod EA, Spitalnik SL. Stored red blood cell transfusions: iron, inflammation, immunity, and infection. Transfusion Clinique et Biologique 2012; 19: 84–9
12. Greer JP, Arber DA, Glader B, et al. Wintrobe's clinical hematology, 13th edn. Philadelphia: Lippincott Williams & Wilkins Publishers, 2014
13. Leaf DE, Rajapurkar M, Lele SS, et al. Increased plasma catalytic iron in patients may mediate acute kidney injury and death following cardiac surgery. Kidney International 2015; 87: 1046–54
14. Karkouti K, Callum JL, Acker JP, Yip P, Rao V. Red cell transfusion-associated hemolysis in cardiac surgery: an observational cohort study. Anestheisa and Analgesia 2017; 124: 1986–91
15. Vercaemst L. Hemolysis in cardiac surgery patients undergoing cardiopulmonary bypass: a review in search of a treatment algorithm. Journal of ExtraCorporeal Technology 2008; 40: 257–67
16. Ganz T, Nemeth E. Hepcidin and iron homeostasis. Biochimica et Biophysica Acta 2012; 1823: 1434–43
17. Rochette L, Gudjoncik A, Guenancia C, Zeller M, Cottin Y, Vergely C. The iron-regulatory hormone hepcidin: a possible therapeutic target? Pharmacology and Therapeutics 2015; 146: 35–52
18. Ashby DR, Gale DP, Busbridge M, et al. Erythropoietin administration in humans causes a marked and prolonged reduction in circulating hepcidin. Haematologica 2010; 95: 505–8
19. Nairz M, Haschka D, Demetz E, Weiss G. Iron at the interface of immunity and infection. Frontiers in Pharmacology 2014; 5: 152
20. World Health Organization Haemoglobin concentrations for the diagnosis of anaemic and assessment of severity Vitamin and Mineral Nutrition Information System Geneva, World Health Organization, 2011 (WHO/NMH/NHD/MNM/111) http://www.who.int/vmnis/indicators/haemoglobin.pdf (accessed 31/1/2018)
21. Karkouti K. Transfusion and risk of acute kidney injury in cardiac surgery. British Journal of Anaesthesia 2012; 109(Suppl 1): i29–38
22. Vermeulen Windsant IC, Hanssen SJ, Buurman WA, Jacobs MJ. Cardiovascular surgery and organ damage: time to reconsider the role of hemolysis. Journal of Thoracic and Cardiovascular Surgery 2011; 142: 1–11
23. Allison PD. Logistic regression using SAS: theory and application, 2nd edn. Cary, NC: SAS Institute Inc, 2012
24. Vittinghoff E, McCulloch CE. Relaxing the rule of ten events per variable in logistic and Cox regression. American Journal of Epidemiology 2007; 165: 710–18
25. Billings FT, Pretorius M, Schildcrout JS, et al. Obesity and oxidative stress predict AKI after cardiac surgery. Journal of the American Society of Nephrology 2012; 23: 1221–8
26. Thakar CV, Arrigain S, Worley S, Yared JP, Paganini EP. A clinical score to predict acute renal failure after cardiac surgery. Journal of the American Society of Nephrology 2005; 16: 162–8
27. Scindia Y, Dey P, Thirunagari A, et al. Hepcidin mitigates renal ischemia-reperfusion injury by modulating systemic iron homeostasis. Journal of the American Society of Nephrology 2015; 26: 2800–14
28. Ho J, Reslerova M, Gali B, et al. Urinary hepcidin-25 and risk of acute kidney injury following cardiopulmonary bypass. Clinical Journal of the American Society of Nephrology 2011; 6: 2340–6
29. Ho J, Lucy M, Krokhin O, et al. Mass spectrometry-based proteomic analysis of urine in acute kidney injury following cardiopulmonary bypass: a nested case-control study. American Journal of Kidney Disease 2009; 53: 584–95
30. Haase-Fielitz A, Mertens PR, Plass M, et al. Urine hepcidin has additive value in ruling out cardiopulmonary bypass-associated acute kidney injury: an observational cohort study. Critical Care 2011; 15: R186
31. Hung M, Ortmann E, Besser M, et al. A prospective observational cohort study to identify the causes of anaemia and association with outcome in cardiac surgical patients. Heart 2015; 101: 107–12
32. Munoz M, Acheson AG, Auerbach M, et al. International consensus statement on the peri-operative management of anaemia and iron deficiency. Anaesthesia 2017; 72: 233–47
33. Chau M, Richards T, Evans C, Butcher A, Collier T, Klein A. The UK Cardiac and Vascular Surgery Interventional Anaemia Response (CAVIAR) Study: protocol for an observational cohort study to determine the impact and effect of preoperative anaemia management in cardiac and vascular surgical patients. British Medical Journal Open 2017; 7: e014872